drugset / Trial / NCT01772719
Overcoming Chemotherapy Resistance In Refractory Multiple Myeloma With Simvastatin and Zoledronic Acid
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to examine the effect of simvastatin and zoledronic acid on M-protein and/or free light chains when added to conventional chemotherapy for the treatment of multiple myeloma patients.
Timeline
- Start
- 2012-08
- Primary completion
- 2016-11
- Completion
- 2016-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Simvastatin | Small molecule | 80 mg | Oral |
| Subject | Zoledronic acid | Other / unclassified | 4 mg | Intravenous |